Glaucoma prevalence appears higher than prior research has estimated, with approximately 4.22 million US adults affected.

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...

More than one-third of patients admitted to the hospital for surgery have adverse events, with more than half potentially preventable.

The number of Americans sickened in an E. coli outbreak tied to slivered onions used on McDonald's Quarter Pounders has now risen to 104.

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

There was an increase in dyslipidemia incidence during the COVID-19 pandemic compared with the prepandemic period.